Items where Author is "Wiegert, E."

Article

Mackensen, A. and Haanen, J. B. A. G. and Koenecke, C. and Alsdorf, W. and Wagner-Drouet, E. and Heudobler, D. and Borchmann, P. and Bokemeyer, C. and Klobuch, S. and Smit, E. and Mueller, F. and Desuki, A. and Lueke, F. and Wiegert, E. and Flemmig, C. and Schulz-Eying, C. and Rengstl, B. and Preussner, L. and Tuereci, O. and Sahin, U. (2022) BNT211-01: A phase I trial to evaluate safety and efficacy of CLDN6 CAR T cells and CLDN6-encoding mRNA vaccine-mediated in vivo expansion in patients with CLDN6-positive advanced solid tumours. ANNALS OF ONCOLOGY, 33 (Suppl7). S1404-S1405. ISSN 0923-7534, 1569-8041

Conference or Workshop Item

Haanen, J. B. and Mackensen, A. and Koenecke, C. and Alsdorf, W. and Wagner-Drouet, E. and Heudobler, Daniel and Borchmann, P. and Klobuch, S. and Smit, E. and Bokemeyer, C. and Desuki, A. and Lüke, Florian and Wiegert, E. and Schulz-Eying, C. and Rengstl, B. and Preussner, L. and Türeci, Ö. and Sahin, U. (2022) BNT211: a Phase 1 Study to determine the Safety and Efficacy of CLDN6 CAR T Cells and CARVAC-mediated in vivo Expansion in Patients with CLDN6-positive advanced solid Tumors. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien.

Haanen, J. and Mackensen, A. and Koenecke, C. and Alsdorf, W. and Desuki, A. and Wagner-Drouet, E. and Heudobler, D. and Borchmann, P. and Wiegert, E. and Schulz, C. and Rengstl, B. and Preussner, L. and Tuereci, O. and Sahin, U. (2021) BNT211: A phase I/II trial to evaluate safety and efficacy of CLDN6 CAR-T cells and CARVac-mediated in vivo expansion in patients with CLDN6+advanced solid tumors. In: ESMO Immuno-Oncology Congres, DEC 08-11, 2021, Virtual.